Literature DB >> 27428714

Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.

David K C Cooper1, Ke-Feng Dou, Kai-Shan Tao, Zhao-Xu Yang, A Joseph Tector, Burcin Ekser.   

Abstract

Experience with clinical liver xenotransplantation has largely involved the transplantation of livers from nonhuman primates. Experience with pig livers has been scarce. This brief review will be restricted to assessing the potential therapeutic impact of pig liver xenotransplantation in acute liver failure and the remaining barriers that currently do not justify clinical trials. A relatively new surgical technique of heterotopic pig liver xenotransplantation is described that might play a role in bridging a patient with acute liver failure until either the native liver recovers or a suitable liver allograft is obtained. Other topics discussed include the possible mechanisms for the development of the thrombocytopenis that rapidly occurs after pig liver xenotransplantation in a primate, the impact of pig complement on graft injury, the potential infectious risks, and potential physiologic incompatibilities between pig and human. There is cautious optimism that all of these problems can be overcome by judicious genetic manipulation of the pig. If liver graft survival could be achieved in the absence of thrombocytopenia or rejection for a period of even a few days, there may be a role for pig liver transplantation as a bridge to allotransplantation in carefully selected patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27428714      PMCID: PMC5030131          DOI: 10.1097/TP.0000000000001319

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  97 in total

1.  Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients.

Authors:  M Olausson; L Mjörnstedt; G Nordén; L Rydberg; J Mölne; L Bäckman; S Friman
Journal:  Am J Transplant       Date:  2007-01       Impact factor: 8.086

2.  Hepatic allografts and xenografts in primates.

Authors:  R Y Calne; D R Davis; J R Pena; H Balner; M de Vries; B M Herbertson; P R Millard; V C Joysey; M J Seaman; J R Samuel; J Stibbe; D L Westbroek
Journal:  Lancet       Date:  1970-01-17       Impact factor: 79.321

Review 3.  Controlling coagulation dysregulation in xenotransplantation.

Authors:  Peter J Cowan; Simon C Robson; Anthony J F d'Apice
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

4.  Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.

Authors:  P Ramirez; R Chavez; M Majado; V Munitiz; A Muñoz; Q Hernandez; C G Palenciano; G Pino-Chavez; M Loba; A Minguela; J Yelamos; M R Gago; A S Vizcaino; H Asensi; M G Cayuela; B Segura; F Marin; A Rubio; T Fuente; R Robles; F S Bueno; T Sansano; F Acosta; J M Rodriguez; F Navarro; J Cabezuelo; E Cozzi; D J White; R Y Calne; P Parrilla
Journal:  Transplantation       Date:  2000-10-15       Impact factor: 4.939

5.  Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses.

Authors:  Mohamed Ezzelarab; Corin Ezzelarab; Tyler Wilhite; Goutham Kumar; Hidetaka Hara; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2011 May-Jun       Impact factor: 3.907

6.  Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts.

Authors:  E Cantu; K R Balsara; B Li; C Lau; S Gibson; A Wyse; K Baig; J Gaca; G V Gonzalez-Stawinski; T Nichols; W Parker; R D Davis
Journal:  Am J Transplant       Date:  2006-11-15       Impact factor: 8.086

7.  The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation.

Authors:  Christine L Lau; Edward Cantu; Gonzalo V Gonzalez-Stawinski; Zoie E Holzknecht; Timothy C Nichols; Katherine E Posther; Cory A Rayborn; Jeffrey L Platt; William Parker; R Duane Davis
Journal:  Am J Transplant       Date:  2003-09       Impact factor: 8.086

Review 8.  Alloantibody and xenoantibody cross-reactivity in transplantation.

Authors:  D K C Cooper; Y-L Tseng; S L Saidman
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

9.  Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection.

Authors:  L A Valdivia; J J Fung; A J Demetris; S Celli; F Pan; M Tsugita; T E Starzl
Journal:  Transplantation       Date:  1994-03-27       Impact factor: 4.939

Review 10.  The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.

Authors:  Jiang Li; Mohamed B Ezzelarab; David Ayares; David K C Cooper
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

View more
  15 in total

Review 1.  Regulation of Clinical Xenotransplantation-Time for a Reappraisal.

Authors:  David K C Cooper; Richard N Pierson; Bernhard J Hering; Muhammad M Mohiuddin; Jay A Fishman; Joachim Denner; Curie Ahn; Agnes M Azimzadeh; Leo H Buhler; Peter J Cowan; Wayne J Hawthorne; Takaaki Kobayashi; David H Sachs
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

2.  Xenotransplantation.

Authors:  Srijan Tandukar; Sundaram Hariharan
Journal:  Organogenesis       Date:  2018-09-25       Impact factor: 2.500

3.  Swine Leukocyte Antigen Class II Is a Xenoantigen.

Authors:  Joseph M Ladowski; Luz M Reyes; Gregory R Martens; James R Butler; Zheng-Yu Wang; Devin E Eckhoff; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

Review 4.  Porcine cytochrome P450 3A: current status on expression and regulation.

Authors:  Martin Krøyer Rasmussen
Journal:  Arch Toxicol       Date:  2020-03-14       Impact factor: 5.153

Review 5.  Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress.

Authors:  Liaoran Wang; David K C Cooper; Lars Burdorf; Yi Wang; Hayato Iwase
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 6.  Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.

Authors:  David K C Cooper; Martin Wijkstrom; Sundaram Hariharan; Joshua L Chan; Avneesh Singh; Keith Horvath; Muhammad Mohiuddin; Arielle Cimeno; Rolf N Barth; John C LaMattina; Richard N Pierson
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

7.  Insights Into Pig Liver Xenotransplantation.

Authors:  Rafael Miyashiro Nunes Dos Santos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-04

Review 8.  Xenotransplantation: past, present, and future.

Authors:  Burcin Ekser; Ping Li; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

Review 9.  Natural Scaffolds Used for Liver Regeneration: A Narrative Update.

Authors:  Masoud Vazirzadeh; Negar Azarpira; Parsa Davoodi; Massoud Vosough; Kamran Ghaedi
Journal:  Stem Cell Rev Rep       Date:  2022-03-23       Impact factor: 6.692

10.  Genetic architecture and regulatory impact on hepatic microRNA expression linked to immune and metabolic traits.

Authors:  Siriluck Ponsuksili; Nares Trakooljul; Frieder Hadlich; Fiete Haack; Eduard Murani; Klaus Wimmers
Journal:  Open Biol       Date:  2017-11       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.